Research Keyword: PCR testing

Epidemiology of Onychomycosis in the United States Characterized Using Molecular Methods, 2015–2024

mycolabadmin

This large study examined over 710,000 nail samples to identify which fungi cause nail infections in the United States. Using modern molecular testing combined with microscopic analysis, researchers found that while the fungus T. rubrum is most common, other molds and yeasts cause many infections too. Importantly, women and older adults are more likely to have infections from these other organisms, which are often harder to treat with standard antifungal medications.

Read More »

The diagnosis of mucormycosis by PCR in patients at risk: a systematic review and meta-analysis

mycolabadmin

This study reviews how well a molecular test called PCR can diagnose mucormycosis, a dangerous fungal infection. Researchers analyzed 30 studies covering over 5,000 patient samples and found that PCR works very well for detecting this infection, especially when using samples from the lungs. Blood tests were also effective but slightly less sensitive. The study recommends using PCR as part of updated diagnostic guidelines to help doctors catch this serious infection earlier, potentially improving patient outcomes.

Read More »

ESCMID-EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance

mycolabadmin

This survey examined how well hospitals in Belgium, the Netherlands, and Luxembourg can diagnose and treat serious fungal infections, which are particularly dangerous for people with weakened immune systems. The researchers found that while most hospitals can test fungal samples, not all have access to all necessary diagnostic tools, especially tests for detecting resistant fungi and identifying fungal co-infections. Many hospitals outsource their testing to other facilities, which can delay diagnosis and treatment, and some hospitals lack access to all recommended antifungal medications.

Read More »

Cryptococcus neoformans/gattii and Histoplasma capsulatum var. capsulatum infections on tissue sections: Diagnostic pitfalls and relevance of an integrated histomolecular diagnosis

mycolabadmin

This research addresses the challenge of identifying two common fungal infections (cryptococcosis and histoplasmosis) when examining tissue samples under a microscope. The study found that these infections often look similar and can be confusing for pathologists. The researchers discovered that looking for specific fungal features, particularly ‘dented-looking’ yeasts, can help differentiate cryptococcosis from histoplasmosis. When standard laboratory tests on fresh tissue aren’t available, using molecular testing (genetic analysis) on preserved tissue samples can successfully identify the fungus in about 75% of cases.

Read More »

The diagnosis of mucormycosis by PCR in patients at risk: a systematic review and meta-analysis

mycolabadmin

Mucormycosis is a dangerous fungal infection that kills many patients. Traditional tests like fungal culture are slow and often miss infections. This comprehensive study of 30 research papers shows that PCR testing is very effective at detecting this fungus, with different specimen types having different success rates. Blood tests were easiest to perform and worked well for screening high-risk patients, while fluid from the lungs was the most accurate.

Read More »

ESCMID-EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance

mycolabadmin

This survey examined how well hospitals in Belgium, the Netherlands, and Luxembourg can diagnose and treat serious fungal infections, especially in patients whose immune systems are weakened. The researchers found that while most hospitals have good access to testing and antifungal medications, some important tests are still missing, and many hospitals send samples to other facilities for testing, which can delay treatment. Since this region has unusually high rates of fungal infections that resist common antifungal drugs, improving access to advanced diagnostic tests is crucial for patient survival.

Read More »

PCR enables rapid detection of dermatophytes in practice

mycolabadmin

Researchers in Finland studied how a fast DNA test (PCR) can detect fungal skin infections better than traditional slow culture methods. The new test, called DermaGenius, gives results in just 16 hours instead of 19 days. By 2022, most fungal infection samples were tested using this faster method, which helps doctors treat patients quickly without unnecessary medications.

Read More »
Scroll to Top